Development of dual-activity vectors by co-envelopment of adenovirus and sirna in artificial lipid bilayers

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Yilmazer, Açelya ^a   Tian, Bowen ^b   Kostarelos, Kostas ^a,c,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; LIPOSOME; SMALL INTERFERING RNA; LIPID BILAYER;

ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID BILAYER; LUNG CARCINOMA; PARTICLE SIZE; UTERINE CERVIX CARCINOMA; VIRAL GENE DELIVERY SYSTEM; VIRION; ZETA POTENTIAL; AGAR GEL ELECTROPHORESIS; ATOMIC FORCE MICROSCOPY; CONFOCAL MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN ADENOVIRUS C; IMMUNOBLOTTING; PHOTON CORRELATION SPECTROSCOPY; PROCEDURES; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5; MIRIDAE;

ADENOVIRUSES, HUMAN; BLOTTING, WESTERN; DYNAMIC LIGHT SCATTERING; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GENETIC THERAPY; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; LIPID BILAYERS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; RNA, SMALL INTERFERING;

EID: 84917706730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114985     Document Type: Article

References (30)

1. Zhang Y-A, Nemunaitis J, Samuel SK, Chen P, Shen Y, et al. (2006) Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA. Cancer Res 66: 9736-9743.
2. Zhang H, Wang H, Zhang J, Qian G, Niu B, et al. (2008) Enhanced Therapeutic Efficacy by Simultaneously Targeting Two Genetic Defects in Tumors. Mol Ther 17: 57-64.
3. Pan Q, Liu B, Liu J, Cai R, Liu X, et al. (2008) Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC. Acta Oncol 47: 135-144.
4. Shen W, Wang C-Y, Wang X-H, Fu Z-X (2009) Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 28: 81.
5. Zheng JN, Pei DS, Mao LJ, Liu XY, Mei DD, et al. (2008) Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. Cancer Gene Ther 16: 20-32.
6. Singh R, Al-Jamal KT, Lacerda L, Kostarelos K (2008) Nanoengineering Artificial Lipid Envelopes Around Adenovirus by Self-Assembly. ACS Nano 2: 1040-1050.
7. Singh R, Tian B, Kostarelos K (2008) Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo. FASEB J 22: 3389-3402.
8. Van den Bossche J, Al-Jamal WT, Yilmazer A, Bizzarri E, Tian B, et al. (2011) Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. Biomaterials 32: 3085-3093.
9. Li L-C, Okino ST, Zhao H, Pookot D, Place RF, et al. (2006) Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 103: 17337-17342.
10. Morris KV, Santoso S, Turner A-M, Pastori C, Hawkins PG (2008) Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells. PLoS Genet 4: e1000258.
11. Ciani L, Ristori S, Salvati A, Calamai L, Martini G (2004) DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery: zeta potential measurements and electron spin resonance spectra. Biochim Biophys Acta 1664: 70-79.
12. Wiseman JW, Goddard CA, McLelland D, Colledge WH (2003) A comparison of linear and branched polyethylenimine (PEI) with DCChol//DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo. Gene Ther 10: 1654-1662.
13. Zhang Y, Li H, Sun J, Gao J, Liu W, et al. (2010) DC-Chol/DOPE cationic liposomes: A comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Int J Pharm 390: 198-207.
14. Bauzon M, Hermiston T (2014) Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy. Front Immunol 5: 74.
15. Tada Y, Shimada H, Hiroshima K, Tagawa M (2013) A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine. Biomed Res Int 2013: 572609.
16. Wong HH, Lemoine N, Wang Y (2010) Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles. Viruses 2: 78-106.
17. Zheng J-N, Pei D-S, Sun F-H, Zhang B-F, Liu X-Y, et al. (2009) Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene. Cancer Biol Ther 8: 84-91.
18. Yilmazer A, Al-Jamal WT, Van den Bossche J, Kostarelos K (2013) The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity. Biomaterials 34: 1354-1363.
19. Bates K, Kostarelos K (2013) Carbon nanotubes as vectors for gene therapy: Past achievements, present challenges and future goals. Adv Drug Delivery Rev 65: 2023-2033.
20. Ozpolat B, Sood AK, Lopez-Berestein G (2014) Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Delivery Rev 66: 110-116.
21. Shu Y, Pi F, Sharma A, Rajabi M, Haque F, et al. (2014) Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Adv Drug Delivery Rev 66: 74-89.
22. Eltoukhy AA, Chen D, Alabi CA, Langer R, Anderson DG (2013) Degradable Terpolymers with Alkyl Side Chains Demonstrate Enhanced Gene Delivery Potency and Nanoparticle Stability. Adv Mater 25: 1487-1493.
23. Kanasty R, Dorkin JR, Vegas A, Anderson D (2013) Delivery materials for siRNA therapeutics. Nat Mater 12: 967-977.
24. Abrams MT, Koser ML, Seitzer J, Williams SC, DiPietro MA, et al. (2009) Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Cotreatment. Mol Ther 18: 171-180.
25. Tran MA, Watts RJ, Robertson GP (2009) Use of liposomes as drug delivery vehicles for treatment of melanoma. Pigment Cell Melanoma Res 22: 388-399.
26. Chang Kang H, Bae YH (2011) Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide. Biomaterials 32: 4914-4924.
27. Rhinn H, Largeau C, Bigey P, Kuen RL, Richard M, et al. (2009) How to make siRNA lipoplexes efficient? Add a DNA cargo. Biochim Biophys Acta 1790: 219-230.
28. Tagami T, Barichello JM, Kikuchi H, Ishida T, Kiwada H (2007) The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex. Int JPharm 333: 62-69.
29. Cho SK, Kwon YJ (2012) Simultaneous gene transduction and silencing using stimuli-responsive viral/ nonviral chimeric nanoparticles. Biomaterials 33: 3316-3323.
30. Ozpolat B, Sood AK, Lopez-Berestein G (2009) Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med 267: 44-53.